CCND1 and squamous cell carcinoma: It has also been reported that overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck, and antisense cyclin D1 enhances sensitivity to head and neck cancer cells to cisplatin27, 28.